福建南方制药股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
4
NMPA:4
Drug Approvals
Imatinib Mesylate Tablets
- Product Name
- 甲磺酸伊马替尼片
- Approval Number
- 国药准字H20233687
- Approval Date
- Jun 7, 2023
NMPA
Clinical Trials
No trials found
News
No news found